[1]
“THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020010, Jan. 2020, doi: 10.4084/mjhid.2020.010.